Back to catalog
Melanotan I Astral research vial

Melanotan I

Also known as Afamelanotide · MT-1 · CAS 75921-69-6

α-MSH analog — A linear α-MSH analog studied for melanogenesis and photoprotection pathways in research.

Latest released COA: 99.74%Lyophilized powder

Available vial sizes

  • 10 mg$32.99In stock

From $32.99In stock

View purchase options

Specifications

CAS number75921-69-6
Molecular formulaC78H111N21O19
Molecular weight1646.9 g/mol
FormLyophilized powder
Research use only. Not for human or veterinary use, consumption, diagnosis, treatment, or therapeutic purposes.

Documentation

Certificates of Analysis

Batch-specific, third-party lab certificates. Each COA is published here once its lot has been tested — preview the results, then open the full PDF.

Current released record

AST-MT1-001

Dosage
10 mg
Purity
99.74%
Laboratory
ILS Laboratories
Analyzed
2026-08-06
Open source PDF

View the compound COA record →

Related

More to explore

View all

Research context

Melanotan I research, identity and references

Also known as Afamelanotide, MT-1

How is Melanotan I related to afamelanotide research?

Melanotan I is a linear alpha-MSH analog associated with the afamelanotide research lineage. Clinical publications establish that lineage but do not verify or authorize use of Astral research material.

CAS number75921-69-6
Molecular formulaC78H111N21O19
Molecular weight1646.9 g/mol
SequenceAc-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂

Clinical commentary

  1. Clinical commentary

    An α-MSH analog in erythropoietic protoporphyria.

    Luger TA, Böhm M. Journal of Investigative Dermatology (2015).

    Provides clinical research context for an alpha-MSH analog without making a claim about Astral material.

    PMID 25785940 · DOI 10.1038/jid.2015.16

Investigational-drug review

  1. Investigational-drug review

    Afamelanotide, an agonistic analog of α-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria.

    Minder EI. Expert Opinion on Investigational Drugs (2010).

    Describes afamelanotide's research lineage and melanocortin mechanism.

    PMID 21073357 · DOI 10.1517/13543784.2010.535515

Editorially curated and source-verified; not independently peer-reviewed by Astral. Last source check: 2026-08-04. How sources are selected.

Check released lot evidence →